{\rtf1\ansi\ansicpg1252\cocoartf2822
\cocoatextscaling0\cocoaplatform0{\fonttbl\f0\fswiss\fcharset0 Helvetica;}
{\colortbl;\red255\green255\blue255;}
{\*\expandedcolortbl;;}
\margl1440\margr1440\vieww11520\viewh8400\viewkind0
\pard\tx720\tx1440\tx2160\tx2880\tx3600\tx4320\tx5040\tx5760\tx6480\tx7200\tx7920\tx8640\pardirnatural\partightenfactor0

\f0\fs24 \cf0 Patient Name: Jane Doe\
Patient ID: P-1001\
Date of Birth: 05/11/1963\
Age: 62\
Sex: Female\
Race/Ethnicity: Caucasian\
Height: 165 cm\
Weight: 68 kg\
BMI: 24.9\
\
Chief Complaint:\
   Progressive shortness of breath, fatigue, and weight loss. \
   History of HER2-positive breast cancer with metastatic disease to bone and liver.\
\
History of Present Illness:\
   Patient initially diagnosed with invasive ductal carcinoma of the left breast in 2014. \
   Underwent lumpectomy followed by adjuvant chemotherapy (doxorubicin + cyclophosphamide) and trastuzumab. \
   Relapsed in 2020 with liver metastases confirmed on biopsy. Has received multiple lines of therapy including paclitaxel and pertuzumab. \
   Currently symptomatic with fatigue, pain, and shortness of breath.\
\
Past Medical History:\
   - Hypertension (diagnosed 2008)\
   - Type 2 Diabetes Mellitus (diagnosed 2010)\
   - Hyperlipidemia\
   - Metastatic HER2+ breast cancer (stage IV)\
\
Surgical History:\
   - Lumpectomy, left breast (2014)\
   - Port-a-cath placement (2014)\
   - Liver biopsy (2020)\
\
Allergies:\
   - Penicillin (rash)\
   - Latex (hives)\
\
Medications:\
   - Trastuzumab (Herceptin)\
   - Metformin 500 mg BID\
   - Lisinopril 20 mg daily\
   - Atorvastatin 20 mg nightly\
   - PRN acetaminophen for pain\
\
Family History:\
   - Mother: breast cancer (deceased, age 65)\
   - Father: coronary artery disease\
   - Sister: alive, healthy\
\
Social History:\
   - Never smoker\
   - Occasional wine use\
   - No recreational drug use\
   - Retired teacher, lives with husband\
\
Review of Systems:\
   - General: fatigue, weight loss\
   - Cardiovascular: occasional palpitations\
   - Respiratory: exertional dyspnea\
   - GI: intermittent nausea, poor appetite\
   - MSK: bone pain in spine and pelvis\
\
Physical Examination:\
   Vital Signs: BP 134/78, HR 88, RR 18, Temp 98.4\'b0F, SpO\uc0\u8322  95%\
   - General: thin, fatigued, alert and oriented\
   - HEENT: normal\
   - Chest: clear breath sounds\
   - Cardiovascular: regular rhythm, no murmurs\
   - Abdomen: mild hepatomegaly, no ascites\
   - Extremities: no edema\
   - Neuro: intact\
\
Laboratory Results (Most Recent):\
   - CBC: WBC 6.1, Hb 10.9, Plt 240\
   - CMP: ALT 55, AST 62, Creatinine 0.9, Glucose 145\
   - Tumor Markers: CA 15-3 elevated at 89 U/mL\
\
Imaging:\
   - CT scan (August 2024): multiple liver lesions (largest 3.5 cm), diffuse bone metastases, no lung involvement\
\
Performance Status:\
   ECOG 1 (restricted in strenuous activity but ambulatory)\
\
Assessment:\
   62-year-old female with metastatic HER2-positive breast cancer, liver and bone metastases, progression after trastuzumab and pertuzumab.\
\
Plan:\
   Evaluate eligibility for HER2-targeted clinical trials including novel antibody-drug conjugates and tyrosine kinase inhibitors.\
}